Home » News » CROs/Service Providers » Harlan Laboratories, Fluofarma collaborate

Harlan Laboratories, Fluofarma collaborate

Wednesday, July 16, 2014

Harlan Laboratories, a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS) business, and Fluofarma, a CRO specializing in high content analysis, have partnered to strengthen the companies’ drug discovery and translational medicine services.

Harlan CRS will utilize Fluofarma’s experience in high content analysis, biomarkers quantification and high content histology, including applications to mechanistic toxicology and prediction of toxicity.

“One of our goals is to help our customers reduce the risk of drug attrition during the development process,” said Ciriaco Maraschiello, director of strategic initiatives and director of drug discovery and translational medicine at Harlan CRS.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!